The clinical interview for depression: A comprehensive review of studies and clinimetric properties

Psychotherapy and Psychosomatics

Volumn 80, Issue 1, 2011, Pages 10-27

  Guidi, Jenny ^a   Fava, Giovanni A ^a,b   Bech, Per ^c   Paykel, Eugene ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

^c FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Anxiety disorders; Clinical Interview for Depression; Clinimetrics; Depressive disorder; Rating scales; Subclinical symptoms

Indexed keywords

PLACEBO;

AFFECTIVE PSYCHOSIS; ANXIETY; BEHAVIOR THERAPY; COGNITIVE THERAPY; DATA BASE; DEPRESSION; DISCRIMINANT VALIDITY; EMBASE; FOLLOW UP; HAMILTON SCALE; HUMAN; INTERRATER RELIABILITY; INTERVIEW; MEDLINE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOTHERAPY; PSYCINFO; REVIEW; SENSITIVITY ANALYSIS;

EID: 77958149445     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317532     Document Type: Review

References (211)

1. Fava GA, Tomba E, Grandi S: The road to recovery from depression-Don't drive today with yesterday's map. Psychother Psychosom 2007; 76: 260-265.
2. Bech P: Fifty years with the Hamilton scales for anxiety and depression. Psychother Psychosom 2009; 78: 202-211.
3. Feinstein AR: The Jones criteria and the challenge of clinimetrics. Circulation 1982; 66: 1-5.
4. Paykel ES: The Clinical Interview for Depression: development, reliability and validity. J Affect Dis 1985; 9: 85-96.
5. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
6. Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26: 57-63.
7. Kendler KS, Munoz RA, Murphy G: The development of the Feighner criteria: a historical perspective. Am J Psychiatry 2010; 167: 134-142.
8. Bech P: Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle. Acta Psychiatr Scand 2009; 120: 400-409.
9. Carney MWP, Roth M, Garside RF: The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 1965; 111: 659-674.
10. Parker G: Diagnosis of depressive disorders; in Herrman H, Maj M, Sartorius N (eds): Depressive Disorders, ed 3. Chichester, Wiley-Blackwell, 2009, pp 1-26.
11. Ramsay JO: The effect of number of rating scale categories on precision of estimation of scale values. Psychometrika 1973; 38: 513-532.
12. Bech P, Allerup A: A categorical approach to depression by a 3-dimensional system. Psychopathology 1986; 19: 327-339.
13. Bech P, Larsen JK, Andersen J: The BPRS-Psychometric developments. Psychopharmacol Bull 1988; 24: 118-121.
14. Bhat A, Rowan PR, Paykel ES: Responses to phenelzine and amitriptyline absence of differential predictors by multiple-regression analysis. J Affect Dis 1984; 6: 209-218.
15. Birtchnell J, Evans C, Deahl M, Masters N: The Depression Screening Instrument (DSI)-A device for the detection of depressive disorders in general practice. J Affect Dis 1989; 16: 269-281.
16. Conti S, Savron G, Bartolucci G, Grandi S, Magelli C, Semprini F, Saviotti FM, Trom-bini G, Fava GA, Magnani B: Cardiac neurosis and psychopathology. Psychother Psychosom 1989; 52: 88-91.
17. Cornwall PL, Scott J: Partial remission in depressive disorders. Acta Psychiatr Scand 1997; 95: 265-271.
18. DeJonghe F, Ameling E, Assies J: An elaborate description of the symptomatology of patients with Research Diagnostic Criteria endogenous depression. J Nerv Ment Dis 1988; 176: 475-479.
19. DiMascio A, Weissman MM, Prusoff BA, Neu C, Zwilling M, Klermqn GL: Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 1979; 36: 1450-1456.
20. Dowson JH: MAO inhibitors in mental disease-Their current status. J Neural Transm 1987; 23(suppl):121-138.
21. Fabbri S: Family intervention approach to loss of clinical effect during antidepressant treatment. Psychother Psychosom 2004; 73: 124.
22. Fava GA: Irritable mood and physical illness. Stress Med 1987; 3: 293-299.
23. Fava GA: Fading of therapeutic effects of al-prazolam in agoraphobia-Case-reports. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 109-112.
24. Fava GA: The concept of recovery in affective disorders. Psychother Psychosom 1996; 65: 2-13.
25. Fava GA: Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 1999; 29: 47-61.
26. Fava GA: Well-being therapy: conceptual and technical issues. Psychother Psychosom 1999; 68: 171-179.
27. Fava GA, Bernardi M, Tomba E, Rafanelli C: Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. Int J Neuropsychopharmacol 2007; 10: 835-838.
28. Fava GA, Fabbri S, Sonino N: Residual symp-toms in depression: an emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 1019-1027. (Pubitemid 35256092)
29. Fava GA, Grandi S, Belluardo P, Savron G, Raffi AR, Conti S, Saviotti FM: Benzodiaz-epines and anxiety sensitivity in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 1163-1168.
30. Fava GA, Grandi S, Canestrari R : Prodromal symptoms in panic disorder-Reply. Am J Psychiatry 1989; 14 6: 1084-1085.
31. Fava GA, Grandi S, Canestrari R: Further discussion of article on prodromal symptoms in panic disorder-Reply. Am J Psychiatry 1990; 147: 1581-1582.
32. Fava GA, Grandi S, Saviotti FM, Bartolucci G, Savron G, Conti S: Blood-injury phobia. Am J Psychiatry 1989; 146: 948-949.
33. Fava GA, Grandi S, Savron G, Conti S, Ra-fanelli C: Panic disorder and suicidal ideation. Am J Psychiatry 1992; 149: 1412 .
34. Fava GA, Kellner R: Prodromal symptoms in affective-disorders. Am J Psychiatry 1991; 14 8: 823-830.
35. Fava GA, Mangelli L: Subclinical symptoms of panic disorder: new insights into pathophysiology and treatment. Psychother Psychosom 1999; 68: 281-289.
36. Fava GA, Molnar G, Grandi S, Sonino N: Prodromal symptoms and intermittent drug medication in mood disorders. Pharmacopsychiatry 1991; 24: 28-30.
37. Fava GA, Rafanelli C, Grandi S, Conti S, Bel-luardo P: The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder-Reply. Arch Gen Psychiatry 1999; 56: 765.
38. Fava GA, Ruini C: Development and characteristics of a well-being enhancing psychotherapeutic strategy: well-being therapy. J Behav Ther Exp Psychiatry 2003; 34: 45-63.
39. Fava GA, Ruini C, Belaise C: The concept of recovery in major depression. Psychol Med 2007; 37: 307-317.
40. Fava GA, Sonino N: Psychosomatic assessment. Psychother Psychosom 2009; 78: 333-341.
41. Fava GA, Tomba E: Increasing psychological well-being and resilience by psychothera-peutic methods. J Pers 2009; 77: 1903-1934.
42. Fava GA, Tossani E: Prodromal stage of major depression. Early Interv Psychiatry 2007; 1: 9-18.
43. Fava GA, Trombini G, Grandi S, Bernardi M, Canestrari R: A psychosomatiCoutpatient clinic. Int J Psychiatry Med 1987; 17: 261-267.
44. Fava GA, Visani D: Psychosocial determinants of recovery in depression. Dialogues Clin Neurosci 2008; 10: 461-472.
45. Gorini A, Riva G: The potentiaLof virtual reality as anxiety management tool: a randomized controlled study in a sample of patients affected by generalized anxiety disorder. Trials 2008; 9: 25.
46. Huyser J, deJonghe F, Sno H, Schalken H: The Depression and Anxiety List (DAL): Description and reliability. Int J Methods Psychiatr Res 1996; 6: 5-8.
47. Kazmina OY, Oleichik IV, Zezyulya TN, Krylova ES: Cognitive behavioural therapy of residual symptoms in patients with juvenile depression. Zhnevrol Psikhiatr Im S S Korsakova 2002; 102: 22-25.
48. Klerman GL, Paykel ES: Depressive pattern, social background, and hospitalization. J Nerv Ment Dis 1970; 150: 466-478.
49. Klerman GL, Paykel ES, Prusoff BA: Antide-pressant drugs and clinical psychopatology; in Cole JO, Friedhof A, Freedman A (eds): Psychopathology and Psychopharmacology. Baltimore, John Hopkins University Press, 1973, pp 172-188.
50. Lopez-Pina JA, Sanchez-Meca J, Rosa-Alcazar AI: The Hamilton Rating Scale for Depression: a meta-analytic reliability generalization study. Int J Clin Health Psychol 2009; 9: 143-159.
51. Matussek P: New trends in analytic therapy for the psychoses. Nervenarzt 1993; 64: 696-705.
52. Parker G, Sengoz A: Descriptors of depression: the importance of agreed definitions. Aust NZ J Psychiatry 1996; 30: 819-823.
53. Paykel ES: Recent life events and clinical depression; in Gunderson EKE, Rahe RH (eds): Life Stress and Illness. Springfield, Thomas, 1974, pp 134-163.
54. Paykel ES: Depression and appetite. J Psychosom Res 1977; 21: 401-407.
55. Paykel ES: Remission and residual symptomatology in major depression. Psychopathology 1998; 31: 5-14.
56. Paykel ES: Achieving gains beyond response. Acta Psychiatr Scand 2002; 106(suppl 415): 12-17.
57. Paykel ES: Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci 2008; 10: 431-437.
58. Paykel ES, Brayne C, Huppert FA, Gill C, Barkley C, Gehlhaar E, Beardsall L, Girling DM, Pollitt P, O'Connor D: Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994; 51: 325-332.
59. Paykel ES, Dienelt M: Suicide attempts following acute depression. J Nerv Ment Dis 1971; 153: 234-243.
60. Paykel ES, Emms EM, Fletcher J, Rassaby ES: Life events and social support in puerperal depression. Br J Psychiatry 1980; 136: 339-346.
61. Paykel ES, Hallowell C, Dressler DM, Shapiro DL, Weissman MM: Treatment of suicide attempters: a descriptive study. Arch Gen Psychiatry 1974; 31: 487-491.
62. Paykel ES, Klerman GL, Prusoff BA: Personality and symptom pattern in depression. Br J Psychiatry 1976; 129: 327-334.
63. Paykel ES, Klerman GL, Prusoff BA: Depressive prognosis and endogenous-neurotic distinction. Psychol Med 1974; 4: 57-64.
64. Paykel ES, Prusoff BA, Tanner J: Temporal stability of symptom patterns in depression. Br J Psychiatry 1976; 128: 369-374.
65. Paykel ES, Vanwoerkom AE, Walters DE, White W, Mercer J: Fengabine in depression-A placebocontrolled study of a GABA agonist. Hum Psychopharmacol Clin Exp 1991; 6: 147-154 .
66. Paykel ES, West PS, Rowan PR, Parker RR: Influence of acetylator phenotype on anti-depressant effects of phenelzine. Br J Psychiatry 1982; 141: 243-248.
67. Prusoff BA, Weissman MM, Tanner J, Lieb J: Symptom reduction in depressed outpatients treated with amitriptyline or maprotiline-Repeated measurement analysis. Compr Psychiatry 1976; 17: 749-754.
68. Rafanelli C, Park SK, Fava GA: New psychotherapeutic approaches to residual symptoms and relapse prevention in unipolar depression. Clin Psychol Psychother 1999; 6: 194-201.
69. Ramosbrieva JA, Corderovillafafila A, Ayu-somateos JL, Rios B, Montejo ML, Rivera A, Caballero L, Ponce C, Canas F: Distinct quality of depressed mood-An attempt to develop an objective measure. J Affect Dis 1987; 13: 241-248.
70. Savron G, Fava GA, Grandi S, Rafanelli C, Raffi AR, Belluardo P: Hypochondriacal fears and beliefs in obsessive-compulsive disorder. Acta Psychiatr Scand 1996; 93: 345-348.
71. Savron G, Montanaro R, Mordenti S, Pitti P: Predictors and therapeutic efficacy in the treatment of obsessive-compulsive disorder. Riv Psichiatr 2007; 42: 34-48.
72. Silverman MJ: Quantitative comparison of cognitive behavioral therapy and music therapy research: a methodological best-practices analysis to guide future investigation for adult psychiatric patients. J Music Ther 2008; 45: 457-506.
73. Sonino N, Fava GA: Tolerance to antidepres-sant treatment may be overcome by ketocon-azole. Report of two cases. J Psychiatr Res 2003; 37: 171-173.
74. Spoov J, Suominen JY, Lahdelmarl, Katila H, Kymalainen O, Isometsa E, Liukko H, Auvinen J: Do reversed depressive symptoms occur together as a syndrome? J Affect Dis 1993; 27: 131-134.
75. Teasdale JD, Taylor MJ, Cooper Z, Hayhurst H, Paykel E S: Depressive thinking-Shiftsin construct accessibility or in schematic mental models. J Abnorm Psychol 1995; 104: 500-507.
76. Tomba E, Rafanelli C, Belaise C, Bernardi M, Ottolini F, Fava GA: Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. Riv Psichiatr 2008; 43: 145-150.
77. Tonks CM, Paykel ES, Klerman GL: Clinical depressions among Negroes. Am J Psychiatry 1970; 127: 329-335.
78. Ulusahin A, Basoglu M, Paykel ES: A cross-cultural comparative-study of depressive symptoms in British and Turkish clinical samples. Soc Psychiatry Psychiatr Epidemiol 1994; 29: 31-39.
79. Vittengl JR, Clark LA, Dunn TW, Jarrett RB: Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol 2007; 75: 475-488.
80. Weissman MM, Paykel ES: The Depressed Woman-Astudy of Social Relations. Chicago, University of Chicago Press, 1974.
81. Weissman MM, Pincus C, Radding R, Siegel R: The educated housewife-mild depression and the search for work. Am J Orthopsychiatry 1973; 43: 565-573.
82. Mazure C, Nelson JC, Price LH: Reliability and validity of the symptoms of major depressive illness. Arch Gen Psychiatry 1986; 43: 451-456.
83. Chipman A, Paykel ES: How ill is patient at this time? Cues determining clinician's global judgments. J Consult Clin Psychol 1974; 42: 669-674.
84. Paykel ES, Mangen SP, Griffith JH, Burns TP: Community psychiatric nursing for neurotic patients: a controlled trial. Br J Psychiatry 1982; 140 : 573-581.
85. Paykel ES, Griffith JH: Community psychiatric nursing for neurotic patients-The Springfield Controlled Trial. London, Royal College of Nursing, 1983.
86. Fava GA, Grandi S, Canestrari R : Prodromal symptoms in panic disorder with agoraphobia. Am J Psychiatry 1988; 145: 1564-1567.
87. Fava GA, Kellner R, Lisansky J, Park S, Peri-ni GI, Zielezny M: Rating depression in normals and depressives-Observer versus self-rating scales. J Affect Dis 1986; 11: 29-33.
88. Grandi S, Fava GA, Cunsolo A, Saviotti FM, Ranieri M, Trombini G, Gozzetti G: Rating depression and anxiety after mastectomy-Observer versus self-rating scales. Int J Psychiatry Med 1990; 20: 163-171.
89. Feinstein AR: Clinimetrics. New Haven, Yale University Press, 1987.
90. Fava GA, Kellner R, Park S, Perini GI, Zielezny M, Lisansky J: Hostility and recovery from melancholia. J Nerv Ment Dis 1986; 174: 414-417.
91. Martín del Campo AF, Dowson JH, Herbert J, Paykel ES: Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls. J Affect Dis 2000; 57: 37-47.
92. Grandi S, Fabbri S, Panattoni N, Gonnella E, Marks I: Self-exposure treatment of recurrent nightmares: waiting-list-controlled trial and 4-year follow-up. Psychother Psychosom 2006; 75: 384-388.
93. Rafanelli C, Park SK, Ruini C, Ottolini F, Cazzaro M, Fava GA: Rating well-being and distress. Stress Med 2000; 16: 55-61.
94. Fava GA, Trombini G, Grandi S, Bernardi M, Pasquali Evangelisti L, Santarsiero G, Or-landi C: Depression and anxiety associated with secondary amenorrhea. Psychosomatics 1985; 25: 905-908.
95. Fava GA, Magelli C, Savron G, Conti S, Bar-tolucci G, Grandi S, Semprini F, Saviotti FM, Belluardo P, Magnani B: Neurocirculatory asthenia: a reassessment using modern psychosomatic criteria. Acta Psychiatr Scand 1994; 89: 314-319.
96. Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M: Course of depression in Cush-ing's syndrome: response to treatment and comparison with Graves' disease. Horm Res 1993; 39: 202-206.
97. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F: Clinical correlates of major depression in Cushing's disease. Psychopathology 1998; 31: 302-306.
98. Sonino N, Navarrini C, Ruini C, Fallo F, Bos-caro M, Fava GA: Life events in the patho-genesis of hyperprolactinemia. Eur J Endocrinol 2004; 151: 61-65.
99. Fry RPW, Crisp AH, Beard RW: Sociopsychological factors in chronic pelvic pain: A review. J Psychosom Res 1997; 42: 1-15.
100. Paykel ES, Klerman GL, Prusoff B: Treatment setting and clinical depression. Arch Gen Psychiatry 1970; 22: 11-21.
101. Paykel ES, Prusoff BA, Klerman GL: En-dogeneous-neurotic continuum in depression-Rater independence and factor distributions. J Psychiatr Res 1971; 8: 73-90.
102. Rassaby E, Paykel ES: Factor patterns in depression: a replication study. J Affect Dis 1979; 1: 187-194.
103. Paykel ES: Classification of depressed patients: a cluster analysis derived grouping. Br J Psychiatry 1971; 118: 275-288.
104. Paykel ES, Henderson AL: Application of clusteranalysis in classification of depression-Replication study. Neuropsychobiology 1977; 3: 111-119.
105. Paykel ES: Depressive typologies and response to amitriptyline. Br J Psychiatry 1972; 120: 147-156.
106. Paykel ES, Prusoff BA, Klerman GL, Haskell D, DiMascio A: Clinical response to amitriptyline among depressed women. J Nerv Ment Dis 1973; 156: 149-165.
107. Prusoff BA, Paykel ES: Typological prediction of response to amitriptyline-Replication study. Int Pharmacopsychiatry 1977; 12: 153-159.
108. Paykel ES, Rassaby E: Classification of suicide attempters by clusteranalysis. Br J Psychiatry 1978; 133: 45-52.
109. Haskell DS, DiMascio A, Prusoff B: Rapidity of symptom reduction in depressions treated with amitriptyline. J Nerv Ment Dis 1975; 160: 24-33.
110. Freeling P, Rao BM, Paykel ES, Sireling LI, Burton RH: Unrecognised depression in general practice. BMJ 1985; 290: 1880-1883.
111. Freeling P: Diagnosis and treatment of depression in general-practice. Br J Psychiatry 1993; 163(suppl 20):14-19.
112. Sireling LI, Paykel ES, Freeling P, Rao BM, Patel SP: Depression in general practice: case thresholds and diagnosis. Br J Psychiatry 1985; 147: 113-119.
113. Yiend J, Paykel ES, Merritt R, Lester K, Doll H, Burns T: Long term outcome of primary care depression. J Affect Dis 2009; 118: 79-86.
114. Tylee AT, Freeling P, Kerry S: Why do general practitioners recognize major depression in one woman patient yet miss it in another? Br J Gen Pract 1993; 43: 327-330.
115. Fava GA, Grandi S, Rafanelli C, Saviotti FM, Ballin M, Pesarin F: Hostility and irritable mood in panic disorder with agoraphobia. J Affect Dis 1993; 29: 213-217.
116. Fava GA, Grandi S, Savron G, Bar tolucci G, Santarsiero G, Trombini G, Orlandi C: Psychosomatic assessment of hirsute women. Psychother Psychosom 1989; 51: 96-100.
117. Brophy JJ: Personality disorder, symptoms and dexamethasone suppression in depression. J Affect Dis 1994; 31: 19-27.
118. Fava GA, Grandi S, Rafanelli C, Canestrari R: Prodromal symptoms in panic disorder with agoraphobia: a replication study. J Affect Dis 1992; 26: 85-88.
119. Fava GA, Grandi S, Saviotti FM, Conti S: Hypochondriasis with panic attacks. Psychosomatics 1990; 31: 351-353.
120. Fava GA, Savron G, Rafanelli C, Grandi S, Canestrari R: Prodromal symptoms in obsessive-compulsive disorder. Psychopathology 1996; 29: 131-134.
121. Fava GA, Grandi S, Canestrari R, Molnar G: Prodromal symptoms in primary major depressive disorder. J Affect Dis 1990; 19: 149-152 .
122. Raffi AR, Rondini M, Grandi S, Fava GA: Life events and prodromal symptoms in bulimia nervosa. Psychol Med 2000; 30: 727-731.
123. Raffi AR, Rondini M, Grandi S, Fava GA: The prodromal phase of bulimia nervosa. Riv Psichiatr 2000;35:270-275.
124. Moffic SH, Paykel ES: Depression in medical inpatients. Br J Psychiatry 1975; 126: 346-353.
125. Ottolini F, Modena MG, Rigatelli M: Prodromal symptoms in myocardial infarction. Psychother Psychosom 2005; 74: 323-327.
126. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A: Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995; 25: 1171-1180.
127. Ramana R, Paykel ES, Cooper Z, Hayhurst H, Saxty M, Surtees PG: Remission and relapse in major depression:a 2-year prospective follow-up-study. Psychol Med 1995; 25: 1161-1170.
128. Paykel ES, Cooper Z, Ramana R, Hayhurst H: Life events, social support and marital relationships in the outcome of severe depression. Psychol Med 1996; 26: 121-133.
129. Hayhurst H, Cooper Z, Paykel ES, Vearnals S, Ramana R: Expressed emotion and depression: alongitudinal study. Br J Psychiatry 1997; 171: 439-443.
130. Kennedy N, Abbott R, Paykel ES: Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med 2003; 33: 827-838.
131. Kennedy N, Abbott R, Paykel ES: Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study. Br J Psychiatry 2004; 184: 330-336.
132. Kennedy N, Paykel ES: Residual symptoms at remission from depression: impact on long-term outcome. J Affect Dis 2004; 80: 135-144.
133. Fava GA, Rafanelli C, Ottolini F, Ruini C, Cazzaro M, Grandi S: Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia. J Affect Dis 2001; 65: 185-190.
134. Paykel ES, Penrose RJ, Rassaby E: Depressive classification and prediction of response to phenelzine. Br J Psychiatry 1979; 134: 572-581.
135. Fava GA, Lisansky J, Kellner R, Zielezny M: Treatment responses in primary and secondary melancholia: a preliminary report. J Clin Psychiatry 1985; 46: 332-334.
136. Kellner R: The Brief Rating Scale for Depression; in Sartorius N, Ban TA (eds): Assessment of Depression. New York, Springer, 1986, pp 179-187.
137. Kellner R: A Symptom Questionnaire. J Clin Psychiatry 1987; 48: 268-274.
138. Rowan PR, Paykel ES, Parker RR: Phenel-zine and amitriptyline: effects on symptoms of neurotic depression. Br J Psychiatry 1982; 140: 475-483.
139. Burns T, Paykel ES, Ezekiel A, Lemon S: Care of chronic neurotiCout-patients by community psychiatric nurses: along-term follow-up study. Br J Psychiatry 1991; 158: 685-690.
140. Burns T, Beadsmoore A, Bhat AV, Oliver A, Mathers C: A controlled triaLof home-based acute psychiatric-services. 1. Clinical and sociaLoutcome. Br J Psychiatry 1993; 163: 49-54.
141. Burns T, Raftery J, Beadsmoore A, Mc-Guigan S, Dickson M: A controlled triaLof home-based acute psychiatric-services. 2. Treatment patterns and costs. Br J Psychiatry 1993; 163: 55-61.
142. Paykel ES, DiMascio A, Haskell D, Prusoff BA: Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychol Med 1975; 5: 67-77.
143. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.
144. Paykel ES, Rowan PR, Parker RR, Burns TP: Response to phenelzine and amitriptyline in subtypes of outpatient depression. Arch Gen Psychiatry 1982; 39: 1041-1049.
145. Hollyman JA, Freeling P, Paykel ES, Bhat A, Sedgwick P: Double-blind placebocontrolled triaLof amitriptyline among depressed patients in general-practice. J R Coll Gen Pract 1988; 38: 393-397.
146. Paykel ES, Hollyman JA, Freeling P, Sedg-wick P: Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebocontrolled trial. J Affect Dis 1988; 14: 83-95.
147. Paykel ES: Use of the Hamilton Depression Scale in general practice; in Bech P, Cop-pen A (eds): The Hamilton Scales. Berlin, Springer, 1990, pp 4-47.
148. Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S: Well-being therapy: a novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med 1998; 28: 475-480.
149. Fava GA, Ruini C, Rafanelli C, Finos L, Sal-maso L, Mangelli L, Sirigatti S: Well-being therapy of generalized anxiety disorder. Psychother Psychosom 2005; 74: 26-30.
150. Fava GA, Kellner R, Zielezny M, Grandi S: Hypochondriacal fears and beliefs in agoraphobia. J Affect Dis 1988; 14: 239-244.
151. Fava GA, Zielezny M, Luria E, Canestrari R: Obsessive-compulsive symptoms in agoraphobia: changes with treatment. Psychiatry Res 1988; 23: 57-63.
152. Fava GA, Grandi S, Canestrari R, Grasso P, Pesarin F: Mechanisms of change of panic attacks with exposure treatment of agoraphobia. J Affect Dis 1991; 22: 65-71.
153. Fava GA, Zielezny M, Savron G, Grandi S: Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 1995; 166: 87-92.
154. Fava GA, Rafanelli C, Grandi S, Conti S, Ruini C, Mangelli L, Belluardo P: Long-term outcome of panic disorder with agoraphobia treated by exposure. Psychol Med 2001; 31: 891-898. (Pubitemid 32621897)
155. Fava GA, Grandi S, Canestrari R: Treatment of social phobia by homework exposure. Psychother Psychosom 1989; 52: 209-213.
156. Fava GA, Grandi S, Rafanelli C, Ruini C, Conti S, Belluardo P: Long-term outcome of social phobia treated by exposure. Psychol Med 2001; 31: 899-905.
157. Fava GA, Grandi S, Rafanelli C, Fabbri S, Cazzaro M: Explanatory therapy in hypochondriasis. J Clin Psychiatry 2000; 61: 317-322.
158. Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA: Cognitive-behavioral treatment of residual sy mptoms in primary major depressive disorder. Am J Psychiatry 1994; 151: 1295-1299.
159. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R: Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996; 153: 945-947.
160. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S: Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 1998,161: 1872-1876.
161. Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P: Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry 1998; 55: 816-820.
162. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S: Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 2004; 161: 1872-1876.
163. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M : Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 1999; 56: 829-835.
164. Scott J, Teasdale JD, Paykel ES, Johnson AL, Abbott R, Hayhurst H, Moore R, Garland A: Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. Br J Psychiatry 2000; 177: 440-446.
165. Paykel ES, Scott J, Cornwall PL, Abbott R, Crane C, Pope M, Johnson AL: Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med 2005; 35: 59-68.
166. Fava GA, Savron G, Grandi S, Rafanelli C: Cognitive-behavioral management of drug-resistant major depressive disorder. J Clin Psychiatry 1997; 58: 278-282.
167. Fava GA, Ruini C, Rafanelli C, Grandi S: Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. Am J Psychiatry 2002; 159: 2094-2095.
168. Fabbri S, Fava GA, Rafanelli C, Tomba E: Family intervention approach to loss of clinical effect during long-term antidepres-sant treatment: a pilot study. J Clin Psychiatry 2007; 68: 1348-1351.
169. Fava GA, Savron G, Zielezny M, Grandi S, Rafanelli C, Conti S: Overcoming resistance to exposure in panic disorder with agoraphobia. Acta Psychiatr Scand 1997; 95: 306-312.
170. Norton KRW, Sireling LI, Bhat AV, Rao B, Paykel ES: A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Dis 1984; 7: 297-308.
171. Bech P, Bolwig TG, Kramp P, Rafaelsen OJ: Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale: Evaluation of homogeneity and inter-observer reliability. Acta Psychiatr Scand 1979; 59: 420-430.
172. Guilford JP: Psychometric Methods. New York, McGraw-Hill 1936.
173. Guilford JP: Psychometric Methods, ed 2. New York, McGraw-Hill, 1954.
174. Anastasi A: Differential Psychology, ed 3. New York, MacMillan, 1958.
175. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
176. Hamilton M: Diagnosis and rating of anxiety; in Lader M (ed): Studies of anxiety. Br J Psychiatry 1969; 3(spec publ):76-79.
177. Pichot P, Pull CB, von Frenckell R, Pull MC: Une analyse factorielle de l'échelle d'appréciation de l'anxieté de Hamilton. Psychiatr Fennica 1981; 13: 183-189.
178. Bech P, Allerup P, Maier W, Albus M, Lavori P, Ayuso JL: The Hamilton Scales and the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry 1992;160: 206-211.
179. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
180. Berrios GE, Bulbena-Vilarasa A: The Hamilton Depression Scale and the numerical description of the symptoms of depression; in Bech P, Coppen A (eds): The Hamilton Scales. Berlin, Springer-Verlag, 1990, pp 80-92.
181. Fava GA, Belaise C: A discussion on the role of clinimetrics and the misleading effects of psychometric theory. J Clin Epidemiol 2005; 58: 753-756.
182. Raskin A, Schulterbrandt JG, Reatig N, McKeon JJ: Differential response to chlor-promazine, imipramine, and placebo: astudy of sub-groups of hospitalised depressed patients. Arch Gen Psychiatry 1970; 23: 16 4-173.
183. Guy W: ECDEU Assessment ManuaLof Psychopharmacology, rev ed. Rockville, US Department of Health Education and Welfare, National Institute of Mental Health, 1976.
184. Thomas A, Donnell AJ, Young TR: Factor structure and differential validity of the expanded Brief Psychiatric Rating Scale. Assessment 2004; 11: 177-187.
185. Prusoff BA, Weissman MM: Pharmacological treatment of anxiety in depressed outpatients; in Klein DF, Rabkin J (eds): Anxiety-New Research and Changing Concepts. New York, Raven Press, 1981, pp 341-353.
186. Michael A, Jenaway A, Paykel ES, Herbert J: Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry 2000; 48: 989-995.
187. Raskin A, Schulterbrandt J, Reatig N, McKeon JJ: Replication of factors of psychopathology in interview, ward behaviour and self-report ratings of hospitalized depression. J Nerv Ment Dis 1969; 148: 89-98.
188. Paykel ES, Prusoff BA: Response set and observer set in assessment of depressed patients. Psychol Med 1973; 3: 209-216.
189. Paykel ES, Prusoff BA, Klerman GL, Di-Mascio A: Self-report and clinical interview ratings in depression. J Nerv Ment Dis 1973; 156: 166-182 .
190. 3 H-imipramine binding to freshly prepared platelet membranes in depression. Psychiatry Res 1989; 29: 87-103.
191. 3 H-Imip-ramine binding to previously frozen platelet membranes from depressed patients, before and after treatment. Br J Psychiatry 1990; 157: 208-215.
192. 2-adrenoceptors in depression. J Affect Dis 1989; 17: 219-228.
193. Lisansky J, Fava GA, Buckman MT, Kellner R, Fava M, Zielezny M, Peake GT: Prolactin, amitriptyline, and recovery from depression. Psychopharmacology 1984; 84: 331-335.
194. Lisansky J, Fava GA, Zielezny MA, Morphy MA, Kellner R: Nocturnal prolactin and cortisol secretion and recovery from melancholia. Psychoneuroendocrinology 1987; 12: 303-311.
195. Fava GA, Lisansky J, Buckman M, Kellner R Pathak D, Fava M, Peake GT: Prolactin, cortisol, and antidepressant treatment. Am J Psychiatry 1988; 145: 358-360.
196. Watts FN, Dalgleish T, Bourke P, Healy D: Memory deficit in clinical depression: processing resources and the structure of materials. Psychol Med 1990; 20: 345-349.
197. Elliott R, Sahakian BJ, McKay AP, Her-rod JJ, Robbins TW, Paykel ES: Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol Med 1996; 26: 975-989.
198. Tarbuck AF, Paykel ES: Effects of major depression on the cognitive function of younger and older subjects. Psychol Med 1995; 25: 285-295.
199. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES: Emotional bias and inhibitory control processes in mania and depression. Psychol Med 1999; 29: 1307-1321.
200. Murphy FC, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES, Sahakian BJ: Decision-making cognition in mania and depression. Psychol Med 2001; 31: 679-693.
201. Murphy FC, Michael A, Robbins TW, Saha-kian BJ: Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance. Psychol Med 2003; 33: 455-467.
202. Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L, Cleare A : A mult id imen sional tool to qua n-tify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry 2009; 70: 177-184.
203. Quilty LC, Godfrey KM, Kennedy SH, Bag-by RM: Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression. Psychother Psychosom 2010; 79: 116-122.
204. Cleary P, Guy W: Factor analysis of the Hamilton Depression Scale. Drugs Exp Clin Res 1977; 1: 115-120.
205. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH: Difference in treatment outcome in outpatients with anxious versus nonanxious depression: astAR * D report. Am J Psychiatry 2008; 165: 342-351.
206. Warden D, Trivedi MH, Wisniewski SR, Lesser IM, Mitchell J, Balasubramani GK, Fava M, Shores-Wilson K, Stegman D, Rush AJ: Identifying risk for attrition during treatment for depression. Psychother Psychosom 2009; 78: 372-379.
207. Pigott HE, Leventhal AM, Alter GS, Boren JJ: The current status of antidepressants' efficacy and effectiveness research. Psychother Psychosom 2010; 79: 267-279.
208. Lichtenberg P, Belmaker RH: Subtyping major depressive disorder. Psychother Psychosom 2010; 79: 131-135.
209. Baumeister H, Parker G: A second thought on subtyping major depression. Psychother Psychosom 2010;79:388-389.
210. Bech P: The struggle of subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psychosom 2010;79:331-338.
211. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 1987; 13: 261-276.